Abstract

Background: Clinical and diagnostic challenges are due to the result of a variable presentation of neonatal sepsis and bloodstream infections (BSIs) and uncertain disease epidemiology in children below five years of age. Although the criteria for achieving an adequate blood culture specimen in adults have been well described, there is much more equivocation in the pediatric population, especially for the under-five-year age group. Therefore, the present study is designed to evaluate the etiological profile of BSI among under-five children by the automated BACTEC systems. Materials and Methods: All blood culture samples received in the Department of Microbiology for culture falling in the age group were included in the study for a period of one year from 01 July 2015 to 30 June 2016 using the BD BACTEC FX except in the exclusion criteria. The blood culture was observed in the BD BACTEC FX system for at least five days before being reported as sterile. Results: A total of 1533 samples in the age group of < 5 years and suspected of BSIs were received in the Department of Microbiology, Indira Gandhi Medical College (IGMC), Shimla. Among them, 963 (62.8%) were males, while 570 (37.2%) were females. Among the total of 1533 samples, 604 (39.40%) were found positive in culture, 898 (58.57%) were negative, and 31 (2.02%) were contaminants. Among the 604 positive cases, 390 (64.6%) were men, while 214 (35.4%) were women. S. aureus was the highest among the gram-positive isolates 98 (16.22%), followed by coagulase-negative Staphylococcus, group B Streptococcus, and S. pneumoniae. Among the gram-negative organisms, E. coli 80 (13.24%) was isolated mostly followed by K. pneumoniae 70 (11.58%), P. aeruginosa 68 (11.25%), Salmonella typhi 50 (8.27%), Citrobacter koseri 18 (2.98%), Acinetobacter baumannii 12 (1.98%) and a group of organisms without fermentation 86 (14.23%). Conclusion: There was quite high positivity in culture in the preschool group. Positivity was significantly high in males as compared to females. It is essential to administer appropriate and synergistic antimicrobial agents empirically early and appropriately for treating children under five-year age with BSI.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call